+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Viral Vector Manufacturing - Global Market Trajectory & Analytics

  • ID: 4806192
  • Report
  • May 2020
  • Region: Global
  • 146 pages
  • Global Industry Analysts, Inc
1 of 2
Amid the COVID-19 crisis and the looming economic recession, the Viral Vector Manufacturing market worldwide will grow by a projected US$1 Billion, during the analysis period, driven by a revised compounded annual growth rate (CAGR) of 23.2%. Retroviral Vectors, one of the segments analyzed and sized in this study, is forecast to grow at over 20.5% and reach a market size of US$412.1 Million by the end of the analysis period. An unusual period in history, the coronavirus pandemic has unleashed a series of unprecedented events affecting every industry. The Retroviral Vectors market will be reset to a new normal which going forward in a post COVID-19 era will be continuously redefined and redesigned. Staying on top of trends and accurate analysis is paramount now more than ever to manage uncertainty, change and continuously adapt to new and evolving market conditions.

As part of the new emerging geographic scenario, the United States is forecast to readjust to a 21.9% CAGR. Within Europe, the region worst hit by the pandemic, Germany will add over US$35.1 Million to the region's size over the next 7 to 8 years. In addition, over US$44.7 Million worth of projected demand in the region will come from Rest of the European markets. In Japan, the Retroviral Vectors segment will reach a market size of US$25.7 Million by the close of the analysis period. Blamed for the pandemic, significant political and economic challenges confront China. Amid the growing push for decoupling and economic distancing, the changing relationship between China and the rest of the world will influence competition and opportunities in the Viral Vector Manufacturing market. Against this backdrop and the changing geopolitical, business and consumer sentiments, the world’s second largest economy will grow at 19.7% over the next couple of years and add approximately US$120.6 Million in terms of addressable market opportunity. Continuous monitoring for emerging signs of a possible new world order post-COVID-19 crisis is a must for aspiring businesses and their astute leaders seeking to find success in the now changing Viral Vector Manufacturing market landscape. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others:

Cell and Gene Therapy Catapult, Cobra Biologics, FujiFilm Diosynth Biotechnologies U.S.A, Inc, Lonza Group AG, Merck KgaA, Oxford Biomedica plc, Spark Therapeutics, Inc, uniQure NV

The global analysis and forecast periods covered within the report are 2020-2027 (Current & Future Analysis) and 2012-2019 (Historic Review). Research estimates are provided for 2020, while research projections cover the period 2021-2027.
Note: Product cover images may vary from those shown
2 of 2
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Viral Vector Manufacturing Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
TABLE 1: Viral Vector Manufacturing Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2020-2027
TABLE 2: Viral Vector Manufacturing Market Share Shift across Key Geographies Worldwide: 2020 VS 2027
TABLE 3: Retroviral Vectors (Type) World Market by Region/Country in US$ Thousand:2020 to 2027
TABLE 4: Retroviral Vectors (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2020 VS 2027
TABLE 5: Adenoviral Vectors (Type) Potential Growth Markets Worldwide in US$ Thousand: 2020 to 2027
TABLE 6: Adenoviral Vectors (Type) Market Sales Breakdown by Region/Country in Percentage: 2020 VS 2027
TABLE 7: Adeno-associated Viral Vectors (Type) Geographic Market Spread Worldwide in US$ Thousand: 2020 to 2027
TABLE 8: Adeno-associated Viral Vectors (Type) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027
TABLE 9: Other Viral Vectors (Type) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2020 to 2027
TABLE 10: Other Viral Vectors (Type) Market Share Breakdown by Region/Country:2020 VS 2027
TABLE 11: Pharmaceutical and Biopharmaceutical Companies (End-Use) Worldwide Latent Demand Forecasts in US$ Thousand by Region/Country: 2020-2027
TABLE 12: Pharmaceutical and Biopharmaceutical Companies (End-Use) Distribution of Global Sales by Region/Country: 2020 VS 2027
TABLE 13: Research Institutes (End-Use) Sales Estimates and Forecasts in US$ Thousand by Region/Country for the Years 2020 through 2027
TABLE 14: Research Institutes (End-Use) Global Market Share Distribution by Region/Country for 2020 and 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Viral Vector Manufacturing Market Share (in %) by Company: 2019 & 2025
Market Analytics
TABLE 15: United States Viral Vector Manufacturing Market Estimates and Projections in US$ Thousand by Type: 2020 to 2027
TABLE 16: United States Viral Vector Manufacturing Market Share Breakdown by Type: 2020 VS 2027
TABLE 17: United States Viral Vector Manufacturing Latent Demand Forecasts in US$ Thousand by End-Use: 2020 to 2027
TABLE 18: Viral Vector Manufacturing Market Share Breakdown in the United States by End-Use: 2020 VS 2027
CANADA
TABLE 19: Canadian Viral Vector Manufacturing Market Estimates and Forecasts in US$ Thousand by Type: 2020 to 2027
TABLE 20: Viral Vector Manufacturing Market in Canada: Percentage Share Breakdown of Sales by Type for 2020 and 2027
TABLE 21: Canadian Viral Vector Manufacturing Market Quantitative Demand Analysis in US$ Thousand by End-Use: 2020 to 2027
TABLE 22: Canadian Viral Vector Manufacturing Market Share Analysis by End-Use:2020 VS 2027
JAPAN
TABLE 23: Japanese Market for Viral Vector Manufacturing: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2020-2027
TABLE 24: Japanese Viral Vector Manufacturing Market Share Analysis by Type: 2020 VS 2027
TABLE 25: Japanese Demand Estimates and Forecasts for Viral Vector Manufacturing in US$ Thousand by End-Use: 2020 to 2027
TABLE 26: Viral Vector Manufacturing Market Share Shift in Japan by End-Use:2020 VS 2027
CHINA
TABLE 27: Chinese Viral Vector Manufacturing Market Growth Prospects in US$ Thousand by Type for the Period 2020-2027
TABLE 28: Chinese Viral Vector Manufacturing Market by Type: Percentage Breakdown of Sales for 2020 and 2027
TABLE 29: Chinese Demand for Viral Vector Manufacturing in US$ Thousand by End-Use: 2020 to 2027
TABLE 30: Chinese Viral Vector Manufacturing Market Share Breakdown by End-Use: 2020 VS 2027
EUROPE
Market Facts & Figures
European Viral Vector Manufacturing Market: Competitor Market Share Scenario (in %)or 2019 & 2025
Market Analytics
TABLE 31: European Viral Vector Manufacturing Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025
TABLE 32: European Viral Vector Manufacturing Market Share Shift by Region/Country: 2020 VS 2027
TABLE 33: European Viral Vector Manufacturing Market Estimates and Forecasts in US$ Thousand by Type: 2020-2027
TABLE 34: European Viral Vector Manufacturing Market Share Breakdown by Type: 2020 VS 2027
TABLE 35: European Viral Vector Manufacturing Addressable Market Opportunity in US$ Thousand by End-Use: 2020-2027
TABLE 36: European Viral Vector Manufacturing Market Share Analysis by End-Use: 2020 VS 2027
FRANCE
TABLE 37: Viral Vector Manufacturing Market in France by Type: Estimates and Projections in US$ Thousand for the Period 2020-2027
TABLE 38: French Viral Vector Manufacturing Market Share Analysis by Type: 2020 VS 2027
TABLE 39: Viral Vector Manufacturing Quantitative Demand Analysis in France in US$ Thousand by End-Use: 2020-2027
TABLE 40: French Viral Vector Manufacturing Market Share Analysis: A 7-Year Perspective by End-Use for 2020 and 2027
GERMANY
TABLE 41: Viral Vector Manufacturing Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2020-2027
TABLE 42: German Viral Vector Manufacturing Market Share Breakdown by Type: 2020 VS 2027
TABLE 43: Viral Vector Manufacturing Market in Germany: Annual Sales Estimates and Forecasts in US$ Thousand by End-Use for the Period 2020-2027
TABLE 44: Viral Vector Manufacturing Market Share Distribution in Germany by End-Use: 2020 VS 2027
ITALY
TABLE 45: Italian Viral Vector Manufacturing Market Growth Prospects in US$ Thousand by Type for the Period 2020-2027
TABLE 46: Italian Viral Vector Manufacturing Market by Type: Percentage Breakdown of Sales for 2020 and 2027
TABLE 47: Italian Demand for Viral Vector Manufacturing in US$ Thousand by End-Use: 2020 to 2027
TABLE 48: Italian Viral Vector Manufacturing Market Share Breakdown by End-Use:2020 VS 2027
UNITED KINGDOM
TABLE 49: United Kingdom Market for Viral Vector Manufacturing: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2020-2027
TABLE 50: United Kingdom Viral Vector Manufacturing Market Share Analysis by Type: 2020 VS 2027
TABLE 51: United Kingdom Demand Estimates and Forecasts for Viral Vector Manufacturing in US$ Thousand by End-Use: 2020 to 2027
TABLE 52: Viral Vector Manufacturing Market Share Shift in the United Kingdom by End-Use: 2020 VS 2027
REST OF EUROPE
TABLE 53: Rest of Europe Viral Vector Manufacturing Market Estimates and Forecasts in US$ Thousand by Type: 2020-2027
TABLE 54: Rest of Europe Viral Vector Manufacturing Market Share Breakdown by Type: 2020 VS 2027
TABLE 55: Rest of Europe Viral Vector Manufacturing Addressable Market Opportunity in US$ Thousand by End-Use: 2020-2027
TABLE 56: Rest of Europe Viral Vector Manufacturing Market Share Analysis by End-Use: 2020 VS 2027
ASIA-PACIFIC
TABLE 57: Viral Vector Manufacturing Market in Asia-Pacific by Type: Estimates and Projections in US$ Thousand for the Period 2020-2027
TABLE 58: Asia-Pacific Viral Vector Manufacturing Market Share Analysis by Type:2020 VS 2027
TABLE 59: Viral Vector Manufacturing Quantitative Demand Analysis in Asia-Pacific in US$ Thousand by End-Use: 2020-2027
TABLE 60: Asia-Pacific Viral Vector Manufacturing Market Share Analysis: A 7-Year Perspective by End-Use for 2020 and 2027
REST OF WORLD
TABLE 61: Rest of World Viral Vector Manufacturing Market Estimates and Forecasts in US$ Thousand by Type: 2020 to 2027
TABLE 62: Viral Vector Manufacturing Market in Rest of World: Percentage Share Breakdown of Sales by Type for 2020 and 2027
TABLE 63: Rest of World Viral Vector Manufacturing Market Quantitative Demand Analysisin US$ Thousand by End-Use: 2020 to 2027
TABLE 64: Rest of World Viral Vector Manufacturing Market Share Analysis by End-Use: 2020 VS 2027

IV. COMPETITION
Total Companies Profiled: 46
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll